Does TOFACITINIB Cause Swelling? 7,623 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 7,623 reports of Swelling have been filed in association with TOFACITINIB (XELJANZ XR). This represents 4.9% of all adverse event reports for TOFACITINIB.
7,623
Reports of Swelling with TOFACITINIB
4.9%
of all TOFACITINIB reports
1,562
Deaths
2,472
Hospitalizations
How Dangerous Is Swelling From TOFACITINIB?
Of the 7,623 reports, 1,562 (20.5%) resulted in death, 2,472 (32.4%) required hospitalization, and 1,895 (24.9%) were considered life-threatening.
Is Swelling Listed in the Official Label?
Yes, Swelling is listed as a known adverse reaction in the official FDA drug label for TOFACITINIB.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Swelling?
ADALIMUMAB (10,906)
METHOTREXATE (10,702)
ETANERCEPT (10,467)
TOCILIZUMAB (9,420)
ABATACEPT (9,226)
LEFLUNOMIDE (8,885)
RITUXIMAB (8,477)
PREDNISONE (7,968)
HYDROXYCHLOROQUINE (7,937)
CERTOLIZUMAB PEGOL (7,748)
Which TOFACITINIB Alternatives Have Lower Swelling Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN